TRADES
Latest Trades
56
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 27 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 88,993 0.0386
ARKG 26 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 182,409 0.0773
ARKG 23 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 58,244 0.0247
ARKG 22 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 14,067 0.0058
ARKG 21 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 65,060 0.0269
ARKG 20 Jul 2021 Buy IONS IONIS PHARMACEUTICALS INC 54,702 0.0232
ARKG 29 Jun 2021 Buy IONS IONIS PHARMACEUTICALS INC 268,748 0.1112
ARKG 28 Jun 2021 Buy IONS IONIS PHARMACEUTICALS INC 325,571 0.1366
ARKG 25 Jun 2021 Buy IONS IONIS PHARMACEUTICALS INC 112,462 0.0473
ARKG 17 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 36,648 0.0181
ARKG 14 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 159,649 0.0787
ARKG 13 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 158,025 0.0777
ARKG 12 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 130,900 0.0617
ARKG 11 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 108,046 0.0497
ARKG 10 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 134,100 0.0605
ARKG 7 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 333,215 0.1467
ARKG 6 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 361,351 0.1568
ARKG 5 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 128,664 0.0632
ARKG 4 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 482,340 0.2281
ARKG 3 May 2021 Buy IONS IONIS PHARMACEUTICALS INC 308,896 0.1417
ARKG 30 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 84,878 0.0379
ARKG 29 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 128,124 0.0572
ARKG 28 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 29,941 0.0131
ARKG 27 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 161,563 0.0706
ARKG 26 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 76,959 0.0334
ARKG 23 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 78,639 0.0346
ARKG 22 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 18,496 0.0081
ARKG 21 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 108,698 0.0467
ARKG 20 Apr 2021 Buy IONS IONIS PHARMACEUTICALS INC 90,284 0.0391
ARKG 24 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 310,023 0.1489
ARKG 23 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 584,838 0.2705
ARKG 22 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 46,225 0.0254
ARKG 17 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 90,493 0.0481
ARKG 16 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 214,492 0.1168
ARKG 15 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 12,557 0.0067
ARKG 12 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 79,806 0.0432
ARKG 11 Mar 2021 Buy IONS IONIS PHARMACEUTICALS INC 55,889 0.0298
ARKG 29 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 67,820 0.0400
ARKG 28 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 28,000 0.0200
ARKG 27 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 91,851 0.0518
ARKG 26 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 134,100 0.0761
ARKG 25 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 176,756 0.0952
ARKG 22 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 77,059 0.0415
ARKG 21 Jan 2021 Buy IONS IONIS PHARMACEUTICALS INC 53,044 0.0290
ARKG 29 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 12,707 0.0099
ARKG 28 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 201,100 0.1566
ARKG 24 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 24,779 0.0191
ARKG 21 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 49,817 0.0407
ARKG 18 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 45,550 0.0391
ARKG 17 Dec 2020 Buy IONS IONIS PHARMACEUTICALS INC 152,185 0.1265
ARKG 21 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 43,644 0.0716
ARKG 20 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 44,012 0.0696
ARKG 19 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 25,277 0.0393
ARKG 14 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 62,339 0.1016
ARKG 13 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 89,700 0.1437
ARKG 12 Oct 2020 Buy IONS IONIS PHARMACEUTICALS INC 72,902 0.1200
Latest Blogs
Cathie Wood's ARK Invest sells nearly 34,000 shares of Tesla

On Monday, a large number of shares of an exchange-traded fund (ETF) managed by ETF star Cathie Wood were sold. In particular, this fund sold nearly 34,000 shares of Tesla Inc. (NASDAQ: TSLA), despite the fact that the fund's price had increased by more than 1 percent on the day. It should be noted that the fund has experienced a significant decline over the past year.

 

The ARK Innovation ETF (NYSEARCA: ARKK) was responsible for the sale of 33,919 shares of Tesla. At Monday's closing price, the transaction would have been valued at approximately $34.2 million. Despite the fact that this represents a small portion of the total holdings, every little bit helps. In the last year, the fund has lost 17 percent of its value.

 

Cathie Wood's ARK Transparency ETF (CTRU) is preparing to make its debut on Wednesday, according to the company.

In preparation for Cathie Wood's launch of the ARK Transparency ETF, financial markets are bracing themselves (BATS: CTRU). CTRU is set to launch on Wednesday and will aim to provide investors with exposure to stocks that exhibit the highest levels of transparency, openness, communication, and trust in their operations.

ARK believes that greater transparency fosters greater consumer confidence while also providing investors with long-term growth potential. Because of this, CTRU is designed to track the price movements of the Transparency Index on a continuous basis. The cumulative returns of the S & P 500 and the Transparency Index from October 1, 2016, to September 30, 2021, are depicted in the chart below.

The new fund will have an expense ratio of 0.55 percent, which is lower than the current one. Furthermore, the ETF will have 100 holdings, with the top three holdings being Cloudflare (NYSE: NET), Bloom Energy (NYSE: BE), and Enphase Energy (NYSE: E) (NASDAQ: ENPH). The top holdings and weightings of CTRU are detailed in the fund's fact sheet.

CTRU will be the ninth exchange-traded fund (ETF) launched by ARK Invest and the third index-based ETF. The fund will trade alongside Wood's flagship fund, the ARK Innovation ETF (NYSEARCA: ARKK), which has amassed over $16 billion in assets under management as of the end of September.

The market's reaction to CTRU's unveiling will be determined in due course. If you're interested in a comparison, Wood's most recent ETF launch, the actively managed ARK Space Exploration & Innovation ETF (BATS: ARKX), saw $295 million worth of value traded in its initial public offering on March 30, 2021.

Although her actively managed exchange-traded funds have performed well this year, Wood's newest fund addition will be launched at a time when the sector has been under fire.

 

The Ark of Cathie Wood Invest falls into a bear market as tech bets turn sour.

Ark Invest's flagship Trade-traded fund has seen its losses for the year soar to 26 cents for every dollar invested, as investors sell off the high-growth but typically unprofitable technology stocks that were responsible for the fund's meteoric rise.

Ark Innovation, owned by trader Cathie Wood, opened down four cents on Monday, following a 12.6 cent decrease the previous week, the company's lowest seven-day stretch since February. Since its February high, the ETF has lost more than 40 cents for every dollar invested.

Ark Innovation is a $21.4 billion actively managed exchange-traded fund that invests in corporations in the United States that are pursuing "disruptive innovation," particularly in areas such as DNA systems, automation, robotics, and electrical power storage, synthetic intelligence, and financial technology.

In the past year, some of Ark's most valuable investments have been hammered, including the real estate marketplace Zillow, the virtual health care organization Teladoc, Zoom — the video clip meeting platform that was just one of the big winners of the pandemic — and Roku, a television streaming company.

 

AJ Bell, the UK's second-largest shown spending platform, claimed that "there has been a waning of enthusiasm for higher-growth tech companies." Russ Mould, the company's financial commitment director, said that A large portion of Ark Innovations' holdings is losing money, which is not ideal in an environment when interest rates are expected to climb.

Although Tesla, Ark's lone most prominent position, has recently weakened, its broad 2021 decline would have been substantially worse had it not been for the company's strong performance in 2018. Tesla is up 38 percent this year despite recent weakness.

Ark Innovation, according to Mould, has faced "some inventory-certain concerns, which have exposed some expensive valuations," in addition to risky technology stocks falling out of favor with investors.

Read full article https://www.clearpublicist.com/cathie-woods-ark-invest-slumps-to-bear-market-as-tech-bets-bitter/.